Insider Trading Activity MyoKardia, Inc. (NASDAQ:MYOK) – Major Shareholder Bought 350,000 shares of Stock

Insider Trading Activity For MyoKardia, Inc. (NASDAQ:MYOK)

Sanofi , Major Shareholder of MyoKardia, Inc. (NASDAQ:MYOK) reportedly Bought 350,000 shares of the company’s stock at an average price of 35.5 for a total transaction amount of $12,425,000.00 SEC Form

Insider Trading History For MyoKardia, Inc. (NASDAQ:MYOK)

On 11/3/2015 Sanofi, Major Shareholder, bought 900,000 with an average share price of $10.00 per share and the total transaction amounting to $9,000,000.00.View SEC Filing

On 11/3/2015 Mark L Perry, Director, bought 5,000 with an average share price of $10.00 per share and the total transaction amounting to $50,000.00.View SEC Filing

On 11/3/2015 Jonathan C Fox, Insider, bought 3,000 with an average share price of $10.00 per share and the total transaction amounting to $30,000.00.View SEC Filing

On 11/3/2015 Anastasios Gianakakos, CEO, bought 1,350 with an average share price of $10.00 per share and the total transaction amounting to $13,500.00.View SEC Filing

On 10/3/2016 Sanofi, Major Shareholder, bought 450,000 with an average share price of $15.00 per share and the total transaction amounting to $6,750,000.00.View SEC Filing

On 3/20/2017 Jake Bauer, Insider, sold 667 with an average share price of $15.00 per share and the total transaction amounting to $10,005.00.View SEC Filing

On 3/20/2017 Anastasios Gianakakos, CEO, sold 1,412 with an average share price of $15.00 per share and the total transaction amounting to $21,180.00.View SEC Filing

Analyst Ratings For MyoKardia, Inc. (NASDAQ:MYOK)
These are 4 Buy Ratings .
The current consensus rating for MyoKardia, Inc. (NASDAQ:MYOK) is Buy (Score: 3.00) with a consensus target price of $43.25 , a potential (7.05% upside)

Analyst Ratings History For MyoKardia, Inc. (NASDAQ:MYOK)

• On 7/12/2016 Credit Suisse Group Reiterated Rating Buy with a price target of $16.00 to $20.00
• On 3/13/2017 Wedbush Reiterated Rating Outperform with a price target of $24.00
• On 8/7/2017 Wells Fargo & Company Reiterated Rating Outperform with a price target of $31.00 to $48.00
• On 8/7/2017 Cowen and Company Boost Price Target of rating Outperform with a price target of $28.00 to $56.00
• On 8/8/2017 BMO Capital Markets Reiterated Rating Buy with a price target of $32.00 to $45.00

Recent Trading Activity for MyoKardia, Inc. (NASDAQ:MYOK)
Shares of MyoKardia, Inc. closed the previous trading session at 42.88 up +2.47 6.13% with 920,794 shares trading hands.